2 min read
ASCO Annual Meeting
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...
Bold Thinking that Delivers Results for RNA Therapies
Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.
While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approved
therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.
In this piece, learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics, including:
- A landmark RNA approval
- Navigating a full-service COVID-19 vaccine trial
- Ensuring a Successful Regulatory Agency Interaction
Meet Veristat. Learn More.
- Partner of Choice for Biologics
- Regulatory Considerations for Biosimilars Development in the US
- Marketing Application Support
- Full-Service Clinical Development Solutions
Get the Latest News
Categories
- Regulatory Consulting (113)
- Regulatory Submissions (108)
- Clinical Trial Regulations (89)
- COVID-19 (46)
- Strategic Consulting (26)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Clinical Operations/Monitoring (8)
- Medical Writing (8)
- Full-Service (7)
- Oncology (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
1 min read
OCT East Coast
Apr 9, 2025 Veristat Events
Meet Veristat at the 16th Annual Outsourcing in Clinical Trials East Coast 2025
Veristat is excited to participate in...